Eversept Partners LP Takes $5.56 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Eversept Partners LP purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 80,303 shares of the company's stock, valued at approximately $5,557,000. Eversept Partners LP owned approximately 0.06% of Henry Schein as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. Olstein Capital Management L.P. grew its stake in Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Private Management Group Inc. grew its stake in shares of Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after buying an additional 18,882 shares in the last quarter. Equitable Trust Co. bought a new stake in shares of Henry Schein in the 4th quarter valued at approximately $417,000. Savant Capital LLC raised its position in Henry Schein by 43.9% during the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock valued at $322,000 after acquiring an additional 1,420 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after acquiring an additional 3,650 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HSIC has been the topic of several analyst reports. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Jefferies Financial Group upped their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Barrington Research reissued an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $1.06 during trading hours on Friday, hitting $65.17. 736,945 shares of the company traded hands, compared to its average volume of 1,623,471. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $7.98 billion, a price-to-earnings ratio of 26.82, a P/E/G ratio of 2.13 and a beta of 0.84. The firm has a 50-day moving average of $69.21 and a 200 day moving average of $71.80. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business posted $0.66 EPS. The firm's quarterly revenue was up 5.8% on a year-over-year basis. On average, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.